Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations

Part of paid clinical trials in Aurora, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT06546943
Status
Recruiting

Conditions

  • Cystic Fibrosis Pulmonary Exacerbation

Eligibility Criteria

Sex
ALL
Age
6 Years - 25 Years
Healthy Volunteers
Not accepted

Study Details

The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).

Key Dates

Start date
Feb 4, 2022
Status verified
Aug 2024
Primary completion
Apr 30, 2025
Completion
Oct 31, 2025

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

CGM standard deviation [ Time Frame: 14 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Hospital Colorado, University of Colorado DenverAuroraColorado80045
Christine Hovater, BS
720-777-3286
Christine L Chan, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Aurora, CO

Related Studies